RXO, Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
RXO$27.92+1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| March 31, | December 31, | |
|---|---|---|
| (Dollars in millions, shares in thousands, except per share amounts) | 2025 | 2024 |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $16 | $35 |
| Accounts receivable, net of $11 and $13 in allowances, respectively | 1,150 | 1,227 |
| Other current assets | 89 | 77 |
| Total current assets | 1,255 | 1,339 |
| Long-term assets | ||
| Property and equipment, net of $333 and $317 in accumulated depreciation, respectively | 143 | 135 |
| Operating lease assets | 256 | 276 |
| Goodwill | 1,124 | 1,123 |
| Identifiable intangible assets, net of $134 and $146 in accumulated amortization, respectively | 484 | 499 |
| Other long-term assets | 42 | 42 |
| Total long-term assets | 2,049 | 2,075 |
| Total assets | $3,304 | $3,414 |
| LIABILITIES AND EQUITY | ||
| Current liabilities | ||
| Accounts payable | $498 | $568 |
| Accrued expenses | 358 | 373 |
| Short-term debt and current maturities of long-term debt | 17 | 17 |
| Short-term operating lease liabilities | 80 | 81 |
| Other current liabilities | 11 | 26 |
| Total current liabilities | 964 | 1,065 |
| Long-term liabilities | ||
| Long-term debt and obligations under finance leases | 387 | 351 |
| Deferred tax liabilities | 77 | 88 |
| Long-term operating lease liabilities | 201 | 215 |
| Other long-term liabilities | 88 | 83 |
| Total long-term liabilities | 753 | 737 |
| Commitments and Contingencies (Note 11) | ||
| Equity | ||
| Preferred stock, $0.01 par value; 10,000 shares authorized; 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.01 par value; 300,000 shares authorized; 163,912 and 162,517 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 2 | 2 |
| Additional paid-in capital | 1,908 | 1,904 |
| Accumulated deficit | (315) | (284) |
| Accumulated other comprehensive loss | (8) | (10) |
| Total equity | 1,587 | 1,612 |
| Total liabilities and equity | $3,304 | $3,414 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.